Stericycle Inc. (NASDAQ:SRCL) – Analysts at Wedbush increased their FY2018 earnings estimates for Stericycle in a research note issued on Sunday. Wedbush analyst A. Kaschalk now anticipates that the brokerage will post earnings per share of $4.89 for the year, up from their prior forecast of $4.82. Wedbush has a “Neutral” rating and a $82.00 price objective on the stock.

Other analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Stericycle from a “strong sell” rating to a “hold” rating in a research note on Monday, October 31st. Jefferies Group restated a “buy” rating and set a $125.00 target price (down previously from $140.00) on shares of Stericycle in a research note on Friday, July 29th. Wellington Shields cut shares of Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Imperial Capital cut shares of Stericycle from an “in-line” rating to an “underperform” rating and cut their target price for the stock from $100.00 to $93.50 in a research note on Friday, July 29th. Finally, Barrington Research restated an “outperform” rating and set a $88.00 target price (down previously from $100.00) on shares of Stericycle in a research note on Wednesday, October 5th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $92.75.

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Shares of Stericycle (NASDAQ:SRCL) traded down 0.30% during trading on Wednesday, hitting $75.40. 521,280 shares of the stock were exchanged. The firm has a 50 day moving average price of $75.47 and a 200 day moving average price of $88.84. The firm has a market capitalization of $6.42 billion, a P/E ratio of 27.41 and a beta of 0.17. Stericycle has a 52 week low of $72.20 and a 52 week high of $128.94.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, October 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.17 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The company had revenue of $890.10 million for the quarter, compared to analyst estimates of $899.87 million. During the same period in the prior year, the business earned $1.08 earnings per share. Stericycle’s quarterly revenue was up 23.9% on a year-over-year basis.

In related news, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 3.30% of the company’s stock.

Several large investors have recently made changes to their positions in SRCL. Balentine LLC raised its stake in shares of Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock valued at $127,000 after buying an additional 160 shares during the period. Pinkerton Retirement Specialists LLC bought a new stake in shares of Stericycle during the second quarter valued at about $131,000. Parkside Financial Bank & Trust raised its stake in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares during the period. Meeder Asset Management Inc. bought a new stake in shares of Stericycle during the second quarter valued at about $155,000. Finally, NEXT Financial Group Inc raised its stake in shares of Stericycle by 78.0% in the third quarter. NEXT Financial Group Inc now owns 1,620 shares of the company’s stock valued at $130,000 after buying an additional 710 shares during the period. 87.98% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This report was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2016/11/23/stericycle-inc-srcl-expected-to-earn-fy2018-earnings-of-4-89-per-share.html.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.